ENOV
Enovis Corporation
Price Chart
Latest Quote
$21.97
+1.12 (+5.37%)
Current Price
| Previous Close | $20.85 |
| Open | $20.91 |
| Day High | $22.00 |
| Day Low | $20.88 |
| Volume | 965,659 |
Stock Information
| Shares Outstanding | 57.56M |
| Total Debt | $1.41B |
| Cash Equivalents | $33.13M |
| Revenue | $2.28B |
| Net Income | $-1.14B |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $1.26B |
| EPS (TTM) | $-19.89 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $2.64B |
| Sales | $2.28B |
| Income | $-1.14B |
| Book/sh | $25.66 |
| Cash/sh | $0.58 |
| Employees | 8K |
Financial Ratios
| Quick Ratio | 0.78 |
| Current Ratio | 2.04 |
| Debt/Eq | 95.34 |
Returns & Margins
| ROA | 1.09% |
| ROE | -55.35% |
| Gross Margin | 61.00% |
| Operating Margin | 3.64% |
| Profit Margin | -49.91% |
Ownership
| Insider Ownership | 1.62% |
| Institutional Ownership | 119.73% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 5.39 |
| PEG | 3.45 |
| P/S | 0.56 |
| P/B | 0.86 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $42.30 |
Technical Indicators
| SMA20 | $22.58 |
| SMA50 | $23.91 |
| SMA200 | $26.36 |
| RSI | 46.77 |
| ATR | 1.3236 |
| Shares Float | 56.59M |
| Short Float | 17.92% |
| Short Ratio | 7.36 |
| Volatility | 1.49 |
| Rel Volume | 1.60 |
Performance History
| Week | +4.02% |
| Month | -14.71% |
| Quarter | -2.66% |
| 6 Months | -15.73% |
| YTD | -17.13% |
| Year | -28.85% |
| 3 Years | -62.11% |
| 5 Years | -72.60% |
| 10 Years | -56.80% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $21.97 | 1,799,400 |
| 2026-06-17 | $20.85 | 1,101,700 |
| 2026-06-16 | $21.58 | 1,076,300 |
| 2026-06-15 | $20.98 | 845,400 |
| 2026-06-12 | $21.80 | 907,700 |
| 2026-06-11 | $21.12 | 1,502,400 |
| 2026-06-10 | $21.97 | 1,515,000 |
| 2026-06-09 | $23.96 | 979,200 |
| 2026-06-08 | $23.68 | 694,100 |
| 2026-06-05 | $23.78 | 709,600 |
| 2026-06-04 | $22.86 | 766,500 |
| 2026-06-03 | $21.56 | 1,040,900 |
| 2026-06-02 | $21.94 | 1,338,400 |
| 2026-06-01 | $21.70 | 1,340,800 |
| 2026-05-29 | $22.68 | 893,900 |
| 2026-05-28 | $23.04 | 1,118,600 |
| 2026-05-27 | $23.11 | 1,289,400 |
| 2026-05-26 | $24.28 | 1,161,200 |
| 2026-05-22 | $24.19 | 912,100 |
| 2026-05-21 | $24.59 | 1,445,200 |
| 2026-05-20 | $26.46 | 596,700 |
| 2026-05-19 | $25.76 | 1,037,800 |
About Enovis Corporation
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
đ° Latest News
Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1
StockStory âĸ 2026-06-11T17:21:37Z
Assessing Enovis (ENOV) Valuation After Recent Share Price Weakness
Simply Wall St. âĸ 2026-06-11T16:18:19Z
Brookdale Senior May 2026 Occupancy Volume Rises to 82.5%
Zacks âĸ 2026-06-09T17:14:00Z
Veeva's Falcon and Vault AI: When Could AI Become a Revenue Driver?
Zacks âĸ 2026-06-09T16:20:00Z
Is Enovis Corporation (ENOV) a High-Growth, Under-Valued Stock?
Insider Monkey âĸ 2026-06-09T13:25:58Z
How The Investment Story For Enovis (ENOV) Is Evolving Without New Analyst Targets
Simply Wall St. âĸ 2026-06-09T01:10:36Z
Is Enovis (ENOV) Using Spinamic To Quietly Redefine Its Orthopedics Innovation Edge?
Simply Wall St. âĸ 2026-06-09T00:17:19Z
3 Reasons ENOV is Risky and 1 Stock to Buy Instead
StockStory âĸ 2026-06-05T22:00:14Z
Enovis (ENOV): Revenue Beat, Margins Expand and Full-Year Outlook Maintained
Insider Monkey âĸ 2026-06-04T21:43:34Z
Spend $75 or Less to Make Contrarian Bets on These 3 Hard-Hit Value Stocks
Barchart âĸ 2026-06-03T18:10:46Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $782,057,000 | $807,604,000 | $632,826,000 | $600,309,000 |
| Cost Of Revenue | $902,789,000 | $926,867,000 | $716,418,000 | $693,718,000 |
| Total Revenue | $2,248,049,000 | $2,107,623,000 | $1,707,197,000 | $1,563,101,000 |
| Operating Revenue | $2,248,049,000 | $2,107,623,000 | $1,707,197,000 | $1,563,101,000 |
| Expenses | ||||
| Interest Expense | $34,823,000 | $57,100,000 | $19,749,000 | $24,052,000 |
| Total Expenses | $2,266,918,000 | $2,211,052,000 | $1,755,571,000 | $1,653,759,000 |
| Other Income Expense | $-1,105,726,000 | $-662,395,000 | $995,000 | $112,641,000 |
| Other Non Operating Income Expenses | $-367,000 | $9,895,000 | $25,663,000 | $2,088,000 |
| Net Non Operating Interest Income Expense | $-34,823,000 | $-57,100,000 | $-19,749,000 | $-24,052,000 |
| Interest Expense Non Operating | $34,823,000 | $57,100,000 | $19,749,000 | $24,052,000 |
| Operating Expense | $1,364,129,000 | $1,284,185,000 | $1,039,153,000 | $960,041,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-1,182,531,000 | $-828,095,000 | $-54,369,000 | $-39,722,000 |
| Net Interest Income | $-34,823,000 | $-57,100,000 | $-19,749,000 | $-24,052,000 |
| Normalized Income | $-309,297,390 | $-296,985,900 | $-34,585,264 | $-127,058,870 |
| Net Income From Continuing And Discontinued Operation | $-1,184,440,000 | $-825,494,000 | $-33,261,000 | $-13,292,000 |
| Total Operating Income As Reported | $-1,124,228,000 | $-775,719,000 | $-65,709,000 | $-71,178,000 |
| Net Income Common Stockholders | $-1,184,440,000 | $-825,494,000 | $-33,261,000 | $-13,292,000 |
| Net Income | $-1,184,440,000 | $-825,494,000 | $-33,261,000 | $-13,292,000 |
| Net Income Including Noncontrolling Interests | $-1,183,620,000 | $-824,815,000 | $-32,731,000 | $-11,759,000 |
| Net Income Discontinuous Operations | $-1,909,000 | $2,601,000 | $21,108,000 | $26,430,000 |
| Net Income Continuous Operations | $-1,181,711,000 | $-827,416,000 | $-53,839,000 | $-38,189,000 |
| Pretax Income | $-1,159,418,000 | $-822,924,000 | $-67,128,000 | $-2,069,000 |
| Special Income Charges | $-1,105,359,000 | $-672,290,000 | $-24,668,000 | $-916,000 |
| Operating Income | $-18,869,000 | $-103,429,000 | $-48,374,000 | $-90,658,000 |
| Depreciation Amortization Depletion Income Statement | $173,646,000 | $165,533,000 | $133,517,000 | $126,301,000 |
| Depreciation And Amortization In Income Statement | $173,646,000 | $165,533,000 | $133,517,000 | $126,301,000 |
| Amortization Of Intangibles Income Statement | $173,646,000 | $165,533,000 | $133,517,000 | $126,301,000 |
| Gross Profit | $1,345,260,000 | $1,180,756,000 | $990,779,000 | $869,383,000 |
| Per Share | ||||
| Diluted EPS | $-20.75 | $-14.93 | $-0.61 | $-0.25 |
| Basic EPS | $-20.75 | $-14.93 | $-0.61 | $-0.25 |
| Other | ||||
| Tax Effect Of Unusual Items | $-232,125,390 | $-141,180,900 | $-4,884,264 | $23,216,130 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $275,142,000 | $191,262,000 | $194,398,000 | $131,140,000 |
| Total Unusual Items | $-1,105,359,000 | $-672,290,000 | $-24,668,000 | $110,553,000 |
| Total Unusual Items Excluding Goodwill | $-1,105,359,000 | $-672,290,000 | $-24,668,000 | $110,553,000 |
| Reconciled Depreciation | $294,378,000 | $284,796,000 | $217,109,000 | $219,710,000 |
| EBITDA (Bullshit earnings) | $-830,217,000 | $-481,028,000 | $169,730,000 | $241,693,000 |
| EBIT | $-1,124,595,000 | $-765,824,000 | $-47,379,000 | $21,983,000 |
| Diluted Average Shares | $57,081,446 | $55,290,958 | $54,981,000 | $53,168,000 |
| Basic Average Shares | $57,081,446 | $55,290,958 | $54,526,230 | $53,168,000 |
| Diluted NI Availto Com Stockholders | $-1,184,440,000 | $-825,494,000 | $-33,261,000 | $-13,292,000 |
| Minority Interests | $-820,000 | $-679,000 | $-530,000 | $-1,533,000 |
| Tax Provision | $22,293,000 | $4,492,000 | $-13,289,000 | $36,120,000 |
| Other Special Charges | $45,818,000 | - | $7,333,000 | $-16,309,000 |
| Impairment Of Capital Assets | $1,049,751,000 | $645,000,000 | $0 | $0 |
| Restructuring And Mergern Acquisition | $9,790,000 | $27,290,000 | $17,335,000 | $17,225,000 |
| Amortization | $173,646,000 | $165,533,000 | $133,517,000 | $126,301,000 |
| Research And Development | $120,332,000 | $91,298,000 | $75,331,000 | $60,827,000 |
| Selling General And Administration | $1,070,151,000 | $1,027,354,000 | $830,305,000 | $772,913,000 |
| Gain On Sale Of Security | - | - | - | $111,469,000 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-465,367,000 | $-447,876,000 | $230,136,000 | $353,770,000 |
| Total Assets | $3,834,737,000 | $4,718,777,000 | $4,509,334,000 | $4,273,248,000 |
| Total Non Current Assets | $2,627,678,000 | $3,572,331,000 | $3,612,815,000 | $3,478,225,000 |
| Other Non Current Assets | $93,347,000 | $88,778,000 | $90,255,000 | $80,288,000 |
| Goodwill And Other Intangible Assets | $1,955,012,000 | $3,010,138,000 | $3,188,256,000 | $3,094,315,000 |
| Other Intangible Assets | $1,236,713,000 | $1,317,429,000 | $1,127,363,000 | $1,110,727,000 |
| Current Assets | $1,207,059,000 | $1,146,446,000 | $896,519,000 | $795,023,000 |
| Other Current Assets | $101,222,000 | $107,882,000 | $71,112,000 | $48,155,000 |
| Prepaid Assets | $42,283,000 | $36,246,000 | $28,901,000 | $28,550,000 |
| Inventory | $584,379,000 | $547,120,000 | $468,832,000 | $426,643,000 |
| Receivables | $442,786,000 | $407,031,000 | $291,483,000 | $267,380,000 |
| Accounts Receivable | $442,786,000 | $407,031,000 | $291,483,000 | $267,380,000 |
| Allowance For Doubtful Accounts Receivable | $-25,609,000 | $-24,466,000 | $-9,731,000 | $-7,965,000 |
| Gross Accounts Receivable | $468,395,000 | $431,497,000 | $301,214,000 | $275,345,000 |
| Cash Cash Equivalents And Short Term Investments | $36,389,000 | $48,167,000 | $36,191,000 | $24,295,000 |
| Cash And Cash Equivalents | $36,389,000 | $48,167,000 | $36,191,000 | $24,295,000 |
| Assets Held For Sale Current | - | - | - | $0 |
| Debt | ||||
| Net Debt | $1,260,404,000 | $1,281,333,000 | $429,973,000 | $234,984,000 |
| Total Debt | $1,379,535,000 | $1,404,301,000 | $536,416,000 | $334,819,000 |
| Long Term Debt And Capital Lease Obligation | $1,319,793,000 | $1,361,934,000 | $514,848,000 | $91,259,000 |
| Long Term Debt | $1,261,793,000 | $1,309,473,000 | $466,164,000 | $40,000,000 |
| Current Debt And Capital Lease Obligation | $59,742,000 | $42,367,000 | $21,568,000 | $243,560,000 |
| Current Debt | $35,000,000 | $20,027,000 | - | $219,279,000 |
| Other Current Borrowings | $35,000,000 | $20,027,000 | - | $219,279,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,342,835,000 | $2,154,448,000 | $1,088,633,000 | $823,447,000 |
| Total Non Current Liabilities Net Minority Interest | $1,744,361,000 | $1,625,450,000 | $719,026,000 | $258,248,000 |
| Other Non Current Liabilities | $424,568,000 | $263,516,000 | $204,178,000 | $166,989,000 |
| Current Liabilities | $598,474,000 | $528,998,000 | $369,607,000 | $565,199,000 |
| Other Current Liabilities | $51,485,000 | $3,648,000 | $278,000 | - |
| Current Deferred Liabilities | $6,495,000 | $6,229,000 | $2,953,000 | $3,560,000 |
| Payables And Accrued Expenses | $375,640,000 | $390,765,000 | $273,829,000 | $266,695,000 |
| Interest Payable | $10,623,000 | $5,841,000 | $3,765,000 | $2,921,000 |
| Payables | $214,709,000 | $200,439,000 | $146,859,000 | $149,304,000 |
| Total Tax Payable | $27,178,000 | $21,341,000 | $14,384,000 | $13,676,000 |
| Accounts Payable | $187,531,000 | $179,098,000 | $132,475,000 | $135,628,000 |
| Liabilities Heldfor Sale Non Current | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $1,489,645,000 | $2,562,262,000 | $3,418,392,000 | $3,448,085,000 |
| Total Equity Gross Minority Interest | $1,491,902,000 | $2,564,329,000 | $3,420,701,000 | $3,449,801,000 |
| Stockholders Equity | $1,489,645,000 | $2,562,262,000 | $3,418,392,000 | $3,448,085,000 |
| Gains Losses Not Affecting Retained Earnings | $-91,363,000 | $-127,892,000 | $-24,881,000 | $-53,430,000 |
| Other Equity Adjustments | $-91,363,000 | $-127,892,000 | $-24,881,000 | $-53,430,000 |
| Retained Earnings | $-1,467,463,000 | $-283,023,000 | $542,471,000 | $575,732,000 |
| Other | ||||
| Ordinary Shares Number | $57,194,781 | $55,876,517 | $54,597,142 | $54,228,619 |
| Share Issued | $57,194,781 | $55,876,517 | $54,597,142 | $54,228,619 |
| Tangible Book Value | $-465,367,000 | $-447,876,000 | $230,136,000 | $353,770,000 |
| Invested Capital | $2,786,438,000 | $3,891,762,000 | $3,884,556,000 | $3,707,364,000 |
| Working Capital | $608,585,000 | $617,448,000 | $526,912,000 | $229,824,000 |
| Capital Lease Obligations | $82,742,000 | $74,801,000 | $70,252,000 | $75,540,000 |
| Total Capitalization | $2,751,438,000 | $3,871,735,000 | $3,884,556,000 | $3,488,085,000 |
| Minority Interest | $2,257,000 | $2,067,000 | $2,309,000 | $1,716,000 |
| Additional Paid In Capital | $3,048,414,000 | $2,973,121,000 | $2,900,747,000 | $2,925,729,000 |
| Capital Stock | $57,000 | $56,000 | $55,000 | $54,000 |
| Common Stock | $57,000 | $56,000 | $55,000 | $54,000 |
| Long Term Capital Lease Obligation | $58,000,000 | $52,461,000 | $48,684,000 | $51,259,000 |
| Current Deferred Revenue | $6,495,000 | $6,229,000 | $2,953,000 | $3,560,000 |
| Current Capital Lease Obligation | $24,742,000 | $22,340,000 | $21,568,000 | $24,281,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $105,112,000 | $85,989,000 | $70,979,000 | $51,384,000 |
| Current Accrued Expenses | $160,931,000 | $190,326,000 | $126,970,000 | $117,391,000 |
| Goodwill | $718,299,000 | $1,692,709,000 | $2,060,893,000 | $1,983,588,000 |
| Net PPE | $579,319,000 | $473,415,000 | $334,304,000 | $303,622,000 |
| Accumulated Depreciation | $-396,814,000 | $-319,524,000 | $-242,450,000 | $-181,183,000 |
| Gross PPE | $976,133,000 | $792,939,000 | $576,754,000 | $484,805,000 |
| Other Properties | $72,256,000 | $68,915,000 | $63,506,000 | $66,881,000 |
| Machinery Furniture Equipment | $801,210,000 | $650,213,000 | $465,599,000 | $375,441,000 |
| Buildings And Improvements | $94,403,000 | $67,142,000 | $41,195,000 | $36,548,000 |
| Land And Improvements | $8,264,000 | $6,669,000 | $6,454,000 | $5,935,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $497,568,000 | $483,582,000 | $406,931,000 | $357,143,000 |
| Work In Process | $54,895,000 | $49,996,000 | $39,310,000 | $28,164,000 |
| Raw Materials | $120,634,000 | $99,636,000 | $88,129,000 | $100,038,000 |
| Treasury Shares Number | - | - | $0 | - |
| Current Provisions | - | - | - | - |
| Inventories Adjustments Allowances | - | - | - | - |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $19,917,000 | $-67,210,000 | $12,765,000 | $-161,311,000 |
| Operating Activities | ||||
| Operating Cash Flow | $217,293,000 | $113,504,000 | $134,988,000 | $-55,861,000 |
| Cash Flow From Continuing Operating Activities | $217,293,000 | $113,504,000 | $134,988,000 | $-55,861,000 |
| Operating Gains Losses | $1,458,000 | $12,341,000 | $-31,517,000 | $-90,721,000 |
| Investing Activities | ||||
| Capital Expenditure | $-197,376,000 | $-180,714,000 | $-122,223,000 | $-105,450,000 |
| Investing Cash Flow | $-179,371,000 | $-955,473,000 | $-242,467,000 | $-176,388,000 |
| Cash Flow From Continuing Investing Activities | $-179,371,000 | $-955,473,000 | $-242,467,000 | $-176,388,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $1,318,000 | $1,874,000 | $1,776,000 | $5,814,000 |
| Financing Cash Flow | $-52,400,000 | $846,821,000 | $127,797,000 | $-465,127,000 |
| Cash Flow From Continuing Financing Activities | $-52,400,000 | $846,821,000 | $127,797,000 | $-465,127,000 |
| Net Other Financing Charges | $-16,793,000 | $-14,280,000 | $-91,174,000 | $1,120,220,000 |
| Net Common Stock Issuance | $1,318,000 | $1,874,000 | $1,776,000 | $5,814,000 |
| Common Stock Issuance | $1,318,000 | $1,874,000 | $1,776,000 | $5,814,000 |
| Other | ||||
| Repayment Of Debt | $-580,925,000 | $-532,773,000 | $-697,805,000 | $-2,106,161,000 |
| Issuance Of Debt | $544,000,000 | $1,392,000,000 | $915,000,000 | $515,000,000 |
| Interest Paid Supplemental Data | $27,445,000 | $51,826,000 | $16,328,000 | $37,089,000 |
| Income Tax Paid Supplemental Data | $18,379,000 | $10,798,000 | $12,515,000 | $31,360,000 |
| End Cash Position | $36,389,000 | $48,167,000 | $44,832,000 | $24,295,000 |
| Beginning Cash Position | $48,167,000 | $44,832,000 | $24,295,000 | $719,370,000 |
| Effect Of Exchange Rate Changes | $2,700,000 | $-1,517,000 | $219,000 | $2,301,000 |
| Changes In Cash | $-14,478,000 | $4,852,000 | $20,318,000 | $-697,376,000 |
| Net Issuance Payments Of Debt | $-36,925,000 | $859,227,000 | $217,195,000 | $-1,591,161,000 |
| Net Long Term Debt Issuance | $-36,925,000 | $859,227,000 | $217,195,000 | $-1,591,161,000 |
| Long Term Debt Payments | $-580,925,000 | $-532,773,000 | $-697,805,000 | $-2,106,161,000 |
| Long Term Debt Issuance | $544,000,000 | $1,392,000,000 | $915,000,000 | $515,000,000 |
| Net Investment Purchase And Sale | $1,601,000 | $-4,845,000 | $0 | $0 |
| Net Business Purchase And Sale | $16,404,000 | $-769,914,000 | $-152,815,000 | $-73,684,000 |
| Sale Of Business | $43,263,000 | $0 | $0 | - |
| Purchase Of Business | $-26,859,000 | $-769,914,000 | $-152,815,000 | $-73,684,000 |
| Net PPE Purchase And Sale | $-197,376,000 | $-180,714,000 | $-89,652,000 | $-102,704,000 |
| Sale Of PPE | $0 | $0 | $32,571,000 | $2,746,000 |
| Purchase Of PPE | $-197,376,000 | $-180,714,000 | $-122,223,000 | $-105,450,000 |
| Change In Working Capital | $15,465,000 | $-13,929,000 | $-27,268,000 | $-222,287,000 |
| Change In Other Working Capital | $39,335,000 | $-9,931,000 | $20,423,000 | $-46,464,000 |
| Change In Payables And Accrued Expense | $-1,137,000 | $13,982,000 | $-6,638,000 | $-11,843,000 |
| Change In Payable | $-1,137,000 | $13,982,000 | $-6,638,000 | $-11,843,000 |
| Change In Account Payable | $-1,137,000 | $13,982,000 | $-6,638,000 | $-11,843,000 |
| Change In Inventory | $-11,981,000 | $39,071,000 | $-24,737,000 | $-118,791,000 |
| Change In Receivables | $-10,752,000 | $-57,051,000 | $-16,316,000 | $-45,189,000 |
| Changes In Account Receivables | $-10,752,000 | $-57,051,000 | $-16,316,000 | $-45,189,000 |
| Other Non Cash Items | $7,378,000 | $5,274,000 | $2,742,000 | $3,921,000 |
| Stock Based Compensation | $32,922,000 | $29,662,000 | $34,065,000 | $38,955,000 |
| Unrealized Gain Loss On Investment Securities | $1,787,000 | $-20,117,000 | $0 | $0 |
| Asset Impairment Charge | $1,049,751,000 | $650,308,000 | $0 | $0 |
| Deferred Tax | $-2,226,000 | $-10,016,000 | $-27,412,000 | $6,320,000 |
| Deferred Income Tax | $-2,226,000 | $-10,016,000 | $-27,412,000 | $6,320,000 |
| Depreciation Amortization Depletion | $294,378,000 | $284,796,000 | $217,109,000 | $219,710,000 |
| Depreciation And Amortization | $294,378,000 | $284,796,000 | $217,109,000 | $219,710,000 |
| Depreciation | $294,378,000 | $284,796,000 | $217,109,000 | $219,710,000 |
| Net Foreign Currency Exchange Gain Loss | $0 | $11,123,000 | $-24,311,000 | $0 |
| Gain Loss On Sale Of PPE | $1,458,000 | $1,218,000 | $-14,539,000 | $352,000 |
| Net Income From Continuing Operations | $-1,183,620,000 | $-824,815,000 | $-32,731,000 | $-11,759,000 |
| Purchase Of Investment | - | $-4,845,000 | $0 | $0 |
| Net Short Term Debt Issuance | - | - | $-242,805,000 | $-904,883,000 |
| Short Term Debt Payments | - | - | $-697,805,000 | $-1,419,883,000 |
| Short Term Debt Issuance | - | - | $455,000,000 | $515,000,000 |
| Amortization Cash Flow | - | - | $140,200,000 | - |
| Amortization Of Intangibles | - | - | $140,200,000 | - |
| Pension And Employee Benefit Expense | - | - | $0 | $0 |
| Gain Loss On Investment Securities | - | - | - | $-111,469,000 |
| Proceeds From Stock Option Exercised | - | - | - | - |
| Gain Loss On Sale Of Business | - | - | - | - |
Fetched: 2026-06-17